{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:06:05Z","timestamp":1793307965404,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["K01TW010271"],"award-info":[{"award-number":["K01TW010271"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P30DK124723-01"],"award-info":[{"award-number":["1P30DK124723-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clbc.2021.11.004","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T20:40:09Z","timestamp":1637613609000},"page":"e463-e472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study"],"prefix":"10.1016","volume":"22","author":[{"given":"Tomi","family":"Akinyemiju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taofik","family":"Oyekunle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omolola","family":"Salako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-4248","authenticated-orcid":false,"given":"Anjali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun","family":"Alatise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Ogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewale","family":"Adeniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Deveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omobolaji","family":"Ayandipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Olajide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalekan","family":"Olasehinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olukayode","family":"Arowolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1927-3992","authenticated-orcid":false,"given":"Adewale","family":"Adisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oludolapo","family":"Afuwape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aralola","family":"Olusanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderemi","family":"Adegoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-1511","authenticated-orcid":false,"given":"Trygve O.","family":"Tollefsbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2219-657X","authenticated-orcid":false,"given":"Donna","family":"Arnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Muehlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Newgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adetola","family":"Daramola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2021.11.004_bib0001","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/bjs.1800790819","article-title":"Breast cancer in Nigerian women","volume":"79","author":"Ihekwaba","year":"1992","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2021.11.004_bib0002","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.canep.2012.04.007","article-title":"Cancer incidence in Nigeria: a report from population-based cancer registries","volume":"36","author":"Jedy-Agba","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0003","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.breast.2005.06.008","article-title":"The severity, outcome and challenges of breast cancer in Nigeria","volume":"15","author":"Adesunkanmi","year":"2006","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2021.11.004_bib0004","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ijc.26088","article-title":"Breast cancer and age in Black and White women in South East England","volume":"130","author":"Jack","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2021.11.004_bib0005","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/jnci\/djn344","article-title":"Recent trends in breast cancer among younger women in the United States","volume":"100","author":"Brinton","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2021.11.004_bib0006","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10549-005-2112-y","article-title":"Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project","volume":"92","author":"Joslyn","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.11.004_bib0007","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-014-2905-y","article-title":"Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies","volume":"145","author":"Trentham-Dietz","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.11.004_bib0008","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10549-011-1929-9","article-title":"Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case-control studies","volume":"132","author":"Woolcott","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.11.004_bib0009","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7","article-title":"Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study","volume":"87","author":"Gao","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2021.11.004_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-9966-27-17","article-title":"Temporal trends in breast cancer presentation in the third world","volume":"27","author":"Anyanwu","year":"2008","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.clbc.2021.11.004_bib0011","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/1596-3519.96880","article-title":"Biology of breast cancer in Nigerian women: a pilot study","volume":"11","author":"Adisa","year":"2012","journal-title":"Ann Afr Med"},{"key":"10.1016\/j.clbc.2021.11.004_bib0012","first-page":"347","article-title":"A comparison of clinicopathological features and molecular markers in British and Nigerian women with breast cancer","volume":"2","author":"Gukas","year":"2008","journal-title":"Clin Med Oncol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0013","first-page":"209","article-title":"Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria","volume":"24","author":"Gukas","year":"2005","journal-title":"West Afr J Med"},{"key":"10.1016\/j.clbc.2021.11.004_bib0014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjc.6604174","article-title":"Early onset of breast cancer in a group of British black women","volume":"98","author":"Bowen","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2021.11.004_bib0015","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/jama.279.22.1801","article-title":"Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer","volume":"279","author":"Lannin","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2021.11.004_bib0016","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jnci\/86.9.705","article-title":"Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States","volume":"86","author":"Elledge","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2021.11.004_bib0017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jss.2007.03.085","article-title":"Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival","volume":"143","author":"Ihemelandu","year":"2007","journal-title":"J Surg Res"},{"key":"10.1016\/j.clbc.2021.11.004_bib0018","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10549-012-2173-7","article-title":"Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women","volume":"135","author":"Agboola","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.11.004_bib0019","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/ijc.27326","article-title":"High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients","volume":"131","author":"Fackenthal","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2021.11.004_bib0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10549-012-2136-z","article-title":"Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry","volume":"134","author":"Zhang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.11.004_bib0021","first-page":"3","article-title":"Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart","volume":"36","author":"Agboola","year":"2014","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0022","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","article-title":"An overview of triple-negative breast cancer","volume":"293","author":"Kumar","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clbc.2021.11.004_bib0023","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2021.11.004_bib0024","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1464-5491.2007.02142.x","article-title":"The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects\u2013a population-based study comparing three different definitions","volume":"24","author":"Nilsson","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.clbc.2021.11.004_bib0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijcard.2006.04.078","article-title":"Prevalence of vascular disease in metabolic syndrome using three proposed definitions","volume":"117","author":"Athyros","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0026","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/01.STR.0000169945.75911.33","article-title":"Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease","volume":"36","author":"Koren-Morag","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.clbc.2021.11.004_bib0027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/ATVBAHA.107.151092","article-title":"Metabolic syndrome pandemic","volume":"28","author":"Grundy","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0028","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2021.11.004_bib0029","first-page":"565","article-title":"Body fat distribution and breast cancer risk: findings from the Nigerian breast cancer study","volume":"23","author":"Ogundiran","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clbc.2021.11.004_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00592-010-0187-3","article-title":"Epidemiological aspects of neoplasms in diabetes","volume":"47","author":"Nicolucci","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0031","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.7314\/APJCP.2012.13.11.5829","article-title":"Hypertension and the risk of breast cancer in Chilean women: a case-control study","volume":"13","author":"Pereira","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2021.11.004_bib0032","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.HYP.34.2.320","article-title":"Hypertension and hormone-related neoplasms in women","volume":"34","author":"Soler","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.clbc.2021.11.004_bib0033","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1758-5996-6-105","article-title":"Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype","volume":"6","author":"Capasso","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.clbc.2021.11.004_bib0034","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00404-011-1837-6","article-title":"Metabolic syndrome is an independent risk factor for breast cancer","volume":"284","author":"Porto","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clbc.2021.11.004_bib0035","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/annonc\/mdr025","article-title":"Metabolic syndrome and the risk of breast cancer in postmenopausal women","volume":"22","author":"Rosato","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0036","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10549-014-3076-6","article-title":"Metabolic syndrome and breast cancer prognosis","volume":"147","author":"Berrino","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.11.004_bib0037","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-009-0591-y","article-title":"The association of metabolic syndrome with triple-negative breast cancer","volume":"121","author":"Maiti","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.11.004_bib0038","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10549-014-3157-6","article-title":"Metabolic syndrome and outcomes following early-stage breast cancer","volume":"148","author":"Calip","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.11.004_bib0039","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.clon.2010.02.001","article-title":"Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer","volume":"22","author":"Healy","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/met.2009.0037","article-title":"Prevalence of metabolic syndrome in a rural community in Nigeria","volume":"8","author":"Adegoke","year":"2010","journal-title":"Metab Syndr Relat Disord."},{"key":"10.1016\/j.clbc.2021.11.004_bib0041","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.dsx.2013.02.014","article-title":"Relationship between socioeconomic status and metabolic syndrome among Nigerian adults","volume":"7","author":"Adedoyin","year":"2013","journal-title":"Diabet Metab Syndr"},{"key":"10.1016\/j.clbc.2021.11.004_bib0042","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/1117-1936.181445","article-title":"Prevalence of metabolic syndrome in urban and suburban Rivers State, Nigeria: international diabetes federation and adult treatment panel III definitions","volume":"17","author":"Siminialayi","year":"2010","journal-title":"Niger Postgrad Med J"},{"key":"10.1016\/j.clbc.2021.11.004_bib0043","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4103\/2230-8210.137494","article-title":"Metabolic syndrome: Performance of five different diagnostic criterias","volume":"18","author":"Onesi","year":"2014","journal-title":"Indian J Endocrinol Metabol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0044","first-page":"126","article-title":"The prevalence of metabolic syndrome in persons with type 2 diabetes at the Lagos University Tteaching Hospital, Lagos, Nigeria","volume":"32","author":"Udenze","year":"2013","journal-title":"West Afr J Med"},{"key":"10.1016\/j.clbc.2021.11.004_bib0045","first-page":"1","article-title":"Collaborative molecular epidemiology study of metabolic dysregulation, DNA methylation, and breast cancer risk among Nigerian women: MEND study objectives and design","volume":"5","author":"Akinyemiju","year":"2019","journal-title":"J Global Oncol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0046","doi-asserted-by":"crossref","unstructured":"Gupta A, Oyekunle T, Salako O, et al. Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study. 2021;12.","DOI":"10.18632\/oncotarget.27991"},{"key":"10.1016\/j.clbc.2021.11.004_bib0047","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2215\/CJN.11951214","article-title":"Human Heredity and Health (H3) in Africa kidney disease research network: a focus on methods in Sub-Saharan Africa","volume":"10","author":"Osafo","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clbc.2021.11.004_bib0048","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.mjafi.2015.11.007","article-title":"Interpretation of ER and Her2neu hormonal receptor in breast cancer","volume":"72","author":"Mukherjee","year":"2016","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.clbc.2021.11.004_bib0049","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.5858\/134.7.e48","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clbc.2021.11.004_bib0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/2007-131-18-ASOCCO","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"131","author":"Wolff","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clbc.2021.11.004_bib0051","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.clbc.2021.11.004_bib0052","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/cancers10090299","article-title":"Metabolic syndrome and the risk of breast cancer and subtypes by race, menopause and BMI","volume":"10","author":"Dibaba","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.clbc.2021.11.004_bib0053","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.5301\/jbm.5000143","article-title":"Decreased serum HDL at initial diagnosis correlates with worse outcomes for triple-negative breast cancer but not non-TNBCs","volume":"30","author":"Fan","year":"2015","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.clbc.2021.11.004_bib0054","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/809291","article-title":"Metabolic syndrome and triple-negative breast cancer: a new paradigm","volume":"2012","author":"Davis","year":"2012","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/j.clbc.2021.11.004_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/189384","article-title":"Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis","volume":"2014","author":"Bhandari","year":"2014","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/j.clbc.2021.11.004_bib0056","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000365951","article-title":"Metabolic syndrome and breast cancer: is there a link?","volume":"9","author":"Hauner","year":"2014","journal-title":"Breast Care"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921003207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921003207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:50Z","timestamp":1761513830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820921003207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1526820921003207"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2021.11.004","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2021.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}